Access
To read this story in full you will need to login or make a payment (see right).
Business
Nature 440, 407 (23 March 2006) | doi:10.1038/440407a; Published online 22 March 2006
In brief
Shares in Human Genome Sciences, the Maryland biotechnology company founded by William Haseltine, tumbled after it announced mixed results from trials of its most promising drug candidate, the hepatitis C treatment Albuferon. The company said that the drug's performance exceeded that of the current market leader, Roche's Pegasys, in patients who took it every two weeks — but not in those who took it once a month.
To read this story in full you will need to login or make a payment (see right).
HTTP Status 500 -
type Exception report
message
description The server encountered an internal error () that prevented it from fulfilling this request.
exception
javax.servlet.ServletException: Servlet execution threw an exception
root cause
java.lang.OutOfMemoryError
note The full stack trace of the root cause is available in the Tomcat logs.